
A biography of cancer, by a physician and oncologist.
Cancer and the science-to-drug pipeline; Pulitzer winner.
Mukherjee, an oncologist, writes a history of cancer framed as a biography of the disease, interleaved with his own fellowship in haematology and oncology at Massachusetts General Hospital. He starts with the Egyptian physician Imhotep's description 4,600 years ago and the excision of the Persian queen Atossa's breast tumour recorded by Herodotus. He traces Hippocrates' and Galen's theory of black bile, its refutation by the dissections of Vesalius and Baillie, William Halsted's radical mastectomy, Emil Grubbe's X-ray treatment and Virchow's identification of leukaemia.
The twentieth-century sections follow Sidney Farber's remissions in childhood leukaemia with antifolates developed by Yellapragada Subbarow, nitrogen mustard against lymphoma, the National Cancer Institute's chemotherapy trials, and the campaign by Farber and Mary Lasker that produced the National Cancer Act of 1971. The book also covers hospice and palliative care and cancer screening. Mukherjee says he wrote it for a patient who wanted to know what they were battling. It won the 2011 Pulitzer Prize for General Nonfiction, and a 2025 edition adds four chapters on HPV, blood-based detection, immunotherapy and the tumour microenvironment.
Investors and general readers who want the history behind oncology drug development and research funding, told by a practising oncologist.
“I loved Mukherjee's 2015 TED Talk and his brilliant book about cancer, The Emperor of All Maladies, which won the Pulitzer Prize in 2011.”
Chosen by shared topics, the entries that hold them, and the people who recommended both.
The gene from Mendel and Darwin to genome editing, beside a family's mental illness.
Recommended by: Bill Gates, Daniel Petre, James Cameron and 1 other
Three generations of the Sackler family and how Purdue Pharma sold OxyContin.
How drug companies distort medical evidence, starting with unpublished trials.
Recommended by: Tim Ferriss
Fraud in data and manufacturing at offshore generic-drug plants.
How Genentech turned genetic engineering into a company, from its founders' accounts.
Recommended by: Laura Deming, Patrick Collison
Inside Vertex's first years: how a new drug company tries to discover a drug.
Recommended by: Laura Deming
As an Amazon Associate I earn from qualifying purchases.